Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03429270
Other study ID # TDOC5Fr-PEDS-01-PR
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 22, 2018
Est. completion date October 17, 2018

Study information

Verified date May 2020
Source Laborie Medical Technologies Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A Pivotal Study to Assess the Performance, Safety and Usability of a New 5 French Air-Charged Catheter for Performing Urodynamic Studies on Pediatric Subjects


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date October 17, 2018
Est. primary completion date October 17, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 12 Years
Eligibility Inclusion Criteria:

- Male and Female (Children and infants, 12 years of age and younger)

- Subjects who are scheduled and normally indicated for urodynamics testing, for any medically necessary reason as per the physician.

Exclusion Criteria:

- Subjects who suffer from bladder infections (not including subjects with asymptomatic bacteruria)

- Subjects with urethral strictures

- Subjects who require the use of a suprapubic catheter

Study Design


Related Conditions & MeSH terms


Intervention

Device:
TDOC 5Fr
A Pivotal Study to Assess the Performance, Safety and Usability of a New 5 French Air-Charged Catheter for Performing Urodynamic Studies on Pediatric Subjects

Locations

Country Name City State
United States University of Virginia Health System - UVA - Pediatric Urology Clinic Charlottesville Virginia
United States J.W. Ruby Memorial Hospital and WVU Medicine Children's Morgantown Virginia

Sponsors (1)

Lead Sponsor Collaborator
Laborie Medical Technologies Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Number of Patients in Which the T-DOC® 5 Fr Catheters Are Safe in Measuring Urodynamic Pressures in Pediatric Subjects (12 Years of Age and Younger). A binary clinician response after each UDS study is used to assess if it is clinically adequate (success) or inadequate (failure) in each patients questionnaire and presented to the clinician where safety (Yes the device is safe and No the device is not safe) will be reported. A minimum of 10 male and 10 female subjects, with an overall minimum of 28, and maximum of 33 subjects. 2 months
Primary The Number of Patients in Which the T-DOC® 5 Fr Catheters Are Effective in Measuring Urodynamic Pressures in Pediatric Subjects (12 Years of Age and Younger). A binary clinician response after each UDS study is used to assess if it is clinically adequate (success) or inadequate (failure) in each patients questionnaire and presented to the clinician where effectiveness (Yes the device is effective and No the device is not effective) will be reported. A minimum of 10 male and 10 female subjects, with an overall minimum of 28, and maximum of 33 subjects. 2 months
See also
  Status Clinical Trial Phase
Completed NCT05058326 - Severity of Fecal Incontinence and Manometric Values Using the Anopress® Device in Women
Recruiting NCT04305743 - Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A Phase 4
Recruiting NCT05362292 - TReating Incontinence for Underlying Mental and Physical Health Phase 4
Active, not recruiting NCT06247033 - Efficacies of Different Managements in Patients With Overactive Bladder With Stroke N/A
Withdrawn NCT03753750 - Noninvasive Spinal Cord Stimulation for Neurogenic and Idiopathic Overactive Bladder N/A
Not yet recruiting NCT05892575 - The Effect of Incontinence Program Applied to Obese Elderly on Quality of Life, Coping and Loneliness N/A
Completed NCT03615001 - T-DOC® NXT Clinical Investigation N/A
Recruiting NCT04094753 - Think Dry: Optimalisation of Diagnostic Process of Urinary Incontinence in Older People
Completed NCT03817931 - Higher Neural Changes Following Anticholinergic, Beta 3 Agonist, or Placebo in Patients With Overactive Bladder Phase 4
Not yet recruiting NCT05948397 - To Use the Combined Version of ICIQ-SF and Quality of Life Scale in Mixed Urinary Incontinence